UNSPSC 51283927: Sulfapyridine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H11N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y5V2N1KE8U, chemically known as sulfanilamide, n(sup 1)-2-pyridyl- but generally known as sulfapyridine, which bears US NIH Compound Identifier 5336. European Medicines Agency schedules Sulfapyridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10724MIG.

UNSPSC 51283927 Sulfapyridine is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and related health-supply systems rather than sulfapyridine specifically. The actual work being solicited under this code reflects state health departments and county public-health bodies procuring pharmaceutical inventory through cooperative purchasing vehicles and competitive bidding, often in support of emergency-response and community-health initiatives. State and local purchasing offices issue these opportunities to stock emergency medications, disease-treatment pharmaceuticals, and public-health supplies on fixed-fee, multi-year terms with renewal options. Issuing bodies include state health departments (such as the Illinois Department of Public Health) and county health authorities (such as Seminole County, Florida). These jurisdictions typically structure awards through piggyback contracts on established cooperative purchasing consortiums or direct competitive bidding, with vendors selected on price and responsiveness and required to meet drug-free workplace, E-Verify, and insurance-coverage standards.

Illinois and Florida represent the visible recent geography, though the code sees activity across multiple states given the distributed nature of public-health procurement. A representative opportunity is the Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse award to Chartwell Rx LLC via the MMCAP Infuse consortium for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, a $2,999,999.11 contract over twelve months with two renewal options, awarded through an Invitation for Bid process. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, a two-year term with one-year renewal option and fixed-fee pricing. Both opportunities emphasize quarterly or regular delivery schedules, vendor responsibility for all shipping costs, and strict compliance with federal workplace and immigration-verification standards.